Cannashield Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Michigan Wholesale Cannabis Tax Shows How Aggressive Taxes Can Backfire
Michigan’s new 24 percent wholesale cannabis tax generated just under $34 million in Q1 2026, far below the projected fiscal year revenue. The bigger lesson is that aggressive cannabis taxes can backfire when operators already face thin margins, falling sales, closures, layoffs, and local revenue pressure.
Global Cannabis Pricing Compression Is The Emerging Market Warning Sign
A new GCNC and Whitney Economics report examines how pricing compression is reshaping cannabis markets across North America, Europe, Latin America, and Israel. The bigger lesson is that emerging markets can look attractive early, but operators and investors need to model margin pressure before supply expands and prices fall.
Auxly’s Q1 Growth Shows How Taxes Still Squeeze Cannabis Operators
Auxly reported higher Q1 2026 revenue driven by flower and pre roll sales, but the bigger business lesson is tax pressure. The company incurred just under $20 million in excise taxes on $59.7 million in cannabis product sales, showing why operators need to track product mix, pricing, and cash flow beyond top line growth.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to get you cover?
Call us on (323)905-3396
or growth@cannashield.io
A new survey found that 15.8 percent of arthritis patients had used cannabis in the past year to control pain, while 26.3 percent had previously used cannabis for medical purposes. The bigger lesson is that patient demand continues to grow, but medical cannabis access still needs responsible education, physician guidance, product quality, and compliant claims.